Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-26 @ 1:32 AM
Study NCT ID:
NCT00151333
Status:
COMPLETED
Last Update Posted:
2009-09-04
First Post:
2005-09-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD)
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-02
Start Date Type:
None
Primary Completion Date:
2005-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-04
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-06
First Submit QC Date:
None
Study First Post Date:
2005-09-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-09-03
Last Update Post Date:
2009-09-04
Last Update Post Date Type:
ESTIMATED